You are here: Industry Insights > Alzheimer

News List

Technique to analyse optical parameters could enhance tip-enhanced Raman spectroscopy europeanpharmaceuticalreview
March 23, 2020
The application of tip-enhanced Raman spectroscopy (TERS) no longer needs to be hampered by a lack of understanding of optical parameters, thanks to new technique, say researchers.
New research discovers cells linked to Alzheimer’s and autism pharmatimes
March 18, 2020
New research by scientists at the Wellcome Sanger Institute has discovered cells that could be linked to both Alzheimer’s and autism.
Samsung Biologics, APRINOIA Enter mAb Pact contractpharma
March 18, 2020
Samsung will provide cell line development, process development, cGMP manufacturing to IND filing support, for Alzheimer's antibody candidate.
Immune cells against Alzheimer's? worldpharmanews
March 11, 2020
Scientists at the German Center for Neurodegenerative Diseases (DZNE), the Ludwig-Maximilians-Universitaet (LMU) Munich and Denali Therapeutics (South San Francisco, CA, USA) ...
Nilvadipine and related drugs could slow Alzheimer’s progression europeanpharmaceuticalreview
March 10, 2020
Researchers have shown that Nilvadipine can slow the rate of cognitive decline in very early- and early-stage Alzheimer’s patients and have received funding to develop improved versions.
Antipsychotic Initiation Ups Risk for Head Injury, TBI in Alzheimer Disease drugs
January 20, 2020
Individuals with Alzheimer disease (AD) initiating antipsychotics have an increased risk for head injuries and traumatic brain injury (TBI), according to a study published online January in the Journal of the American Geriatrics Society.
Tau-PET Signal Predicts Atrophy in Early Alzheimer Disease drugs
January 03, 2020
The global intensity of the tau-positron emission tomography (PET) signal predicts the rate of subsequent atrophy in patients at early symptomatic Alzheimer disease (AD) stages ...
Study Might Point Alzheimer's Research in Whole New Direction drugs
January 03, 2020
A new brain scanning technique is shaking up what researchers thought they knew about Alzheimer's disease.
More Doubt That Plaques in the Brain Cause Alzheimer's drugs
December 31, 2019
For decades, scientists have known that Alzheimer's disease is accompanied by the buildup of clumps of amyloid protein between brain cells. Could these plaques be causing the disease?
Longeveron Completes Enrollment for Alzheimer's Disease Study americanpharmaceuticalreview
December 24, 2019
Longeveron has completed enrollment in its Phase 1 Alzheimer's disease trial. This randomized, double-blind, placebo-controlled study is designed to evaluate the safety and ...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 16 17 Next page